Corrigendum: Randomized, Double Blind, Placebo Controlled, Clinical Trial to Study Ashwagandha Administration in Participants Vaccinated Against COVID-19 on Safety, Immunogenicity, and Protection With COVID-19 Vaccine-A Study Protocol

Front Med (Lausanne). 2022 Mar 29:9:888928. doi: 10.3389/fmed.2022.888928. eCollection 2022.

¹ Center for Rheumatic Diseases, Pune, India.
² Center for Complementary and Integrative Health, Interdisciplinary School of Health Sciences, Savitribai Phule Pune University, Pune, India.
³ Translational Health Science and Technology Institute (THSTI), Faridabad, India.
⁴ Central Council for Research in Ayurvedic Science, New Delhi, India.

Abstract

[This corrects the article DOI: 10.3389/fmed.2022.761655.].

Keywords: Ashwagandha; Ayurveda; COVID-19; Withania somnifera; immunoadjuvant; immunogenicity; vaccine.